Guidelines

Additionally, the study found that Fluarix Quadrivalent reduced healthcare utilization (i.e., antibiotic use, general practitioner visits and emergency department visits) related to confirmed influenza illness.

The product had U.S. sales of roughly $358 million for the 12 months ended October 2017, according to IQVIA data.

The product had U.S. sales of roughly $929 million for the 12 months ended December 2017, according to IQVIA data.

The awards recognize pharmacists and organizations that have made notable contributions to improving their communities’ vaccination rates.

On Friday, CDC reported ILI rates of 7.5% for the week ended Feb. 10.

The Doctors Report Illness Tracker draws from a national database of doctor-diagnosed and reported cases over a period of the past seven days.

The product, which Teva said eliminates the need for hand-breath coordination, is indicated as a maintenance treatment for asthma as a prophylactic therapy in patients ages four years and older.

Strictly judging by the coloring of Walgreens' heat map, the national incidence of influenza illnesses may have reached its peak.